Health Care & Hospital Law
Aug. 10, 2011
Regulators drop investigation of health care chief executive
The U.S. Department of Health and Human Services on Friday ended an investigation of Howard Solomon, CEO of Forest Laboratories Inc., without excluding him from Medicare and other federal health care programs.




Daily Journal Staff Writer
In a case closely watched by pharmaceutical and medical device company executives, the U.S. Department of Health and Human Services' Office of the Inspector General on Friday ended an investigation of Howard Solomon, CEO of Forest Laboratories Inc., without excluding him from Medicare and other federal health care programs.
The OIG put executives in health care and related industries on notice in...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In